Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Mamounas, Eleftherios P Bandos, Hanna Lembersky, Barry C Jeong, Jong-Hyeon Geyer Jr, Charles E Rastogi, Priya Fehrenbacher, Louis Graham, Mark L Chia, Stephen K Brufsky, Adam M Walshe, Janice M Soori, Gamini S Dakhil, Shaker R Seay, Thomas E Wade III, James L McCarron, Edward C Paik, Soonmyung Swain, Sandra M Wickerham, D Lawrence Wolmark, Norman